Left Atrial Remodeling Parameters and Brain Natriuretic Peptide Levels in Nonvalvular Atrial Fibrillation

Area of Science:

• Cardiology
• Biomarkers
• Cardiac Imaging

Background:

• Left atrial (LA) remodeling is a key feature of heart failure with preserved ejection fraction (HFpEF), particularly in patients with atrial fibrillation (AF).
• Brain natriuretic peptide (BNP) is a biomarker used to assess cardiac strain and LA remodeling severity.
• Understanding the relationship between BNP and LA volume index (LAVI) in HFpEF with AF is crucial for patient management.

Purpose of the Study:

• To correlate BNP levels with LAVI in HFpEF patients with nonvalvular AF compared to those in sinus rhythm (SR).
• To evaluate the diagnostic implications of BNP in assessing LA remodeling in these patient groups.
• To investigate potential paradoxes in BNP interpretation within the context of AF and HFpEF.

Main Methods:

• An observational, cross-sectional study involving 340 de novo HFpEF patients (140 AF, 200 SR).
• BNP levels were measured and categorized (low, moderate-high, high).
• LAVI was calculated using echocardiography, and data were analyzed using Spearman correlation and multivariate regression.

Main Results:

• AF patients exhibited higher BNP levels and LAVI compared to SR patients.
• Paradoxically, AF patients with low BNP showed significantly higher LAVI and worse NYHA class symptoms.
• A negative correlation between BNP and severe LAVI was found in AF patients, contrasting with a positive correlation in SR patients.

Conclusions:

• Low BNP levels in HFpEF patients with AF may paradoxically indicate severe LA remodeling and worse symptoms.
• BNP interpretation in HFpEF requires integration with clinical, echocardiographic, and strain data, especially in AF patients.
• Consideration of factors like high BMI and kidney disease is important for optimizing management in these patients.